1 min readFDA-IND Application for Expanded Use & NDC Registrations 01/01/2022FDA-IND Application for Intermediate Size Group Population Expanded Access: 1. Outline of Materials 2. FDA-IND-1571: Expanded Access Form 3. Financial Interests of Investigator Form 4. Statement of Investigators Form 5. Principal Investigator & Co-PI CV 6. Statement of Purpose, Background 7. Proposed Research Project Background8. Current Provisional Patent Claims 9. Clinical Design, Aims, Goals & Budget 10. Research Validation Brain Imaging 11. Research Consent, IND Disclosures 12. Formula: Pharmacology-Toxicology Data 13. Current Thesis Research Outline 14. Commercial Pitch Deck with Societal Impact Statement, Referenced Background, Commercial Potentials Real Time Revenue Model
FDA-IND Application for Intermediate Size Group Population Expanded Access: 1. Outline of Materials 2. FDA-IND-1571: Expanded Access Form 3. Financial Interests of Investigator Form 4. Statement of Investigators Form 5. Principal Investigator & Co-PI CV 6. Statement of Purpose, Background 7. Proposed Research Project Background8. Current Provisional Patent Claims 9. Clinical Design, Aims, Goals & Budget 10. Research Validation Brain Imaging 11. Research Consent, IND Disclosures 12. Formula: Pharmacology-Toxicology Data 13. Current Thesis Research Outline 14. Commercial Pitch Deck with Societal Impact Statement, Referenced Background, Commercial Potentials Real Time Revenue Model
Comentários